36 results on '"Coles, Wynona A."'
Search Results
2. Pentostatin Plus Cyclophosphamide Decrease Graft Rejection in Nonmyeloablative Haploidentical Hematopoietic Cell Transplantation for Sickle Cell Disease
3. Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype
4. Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell Disease
5. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease
6. Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis: A Randomized Controlled Trial
7. Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease
8. Efficacy and safety of endothelin receptor antagonists for Pulmonary Hypertension in adult patients with Sickle Cell Disease.: #117
9. Hemodynamic and Functional Assessment of Patients with Sickle Cell Disease and Pulmonary Hypertension
10. Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease
11. Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality
12. Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension
13. At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT
14. Bone Marrow Characterization in Sickle Cell Disease: Inflammation and Stress Erythropoiesis Lead to Suboptimal CD34 Recovery Compared to Normal Volunteer Bone Marrow
15. Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT
16. Nonmyeloablative Hematopoietic Stem Cell Transplantation (HSCT) Improves Cardiac Function in Patients with Sickle Cell Disease (SCD)
17. Prevalence of Anti-Human Factor VIII Binding IgG Antibodies in Sickle Cell Disease Patients before and after Hematopoietic Stem Cell Transplantation
18. At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation
19. Post-Transplant Cyclophosphamide Improves Engraftment in Patients with Sickle Cell Disease (SCD) and Severe Organ Damage who Undergo Haploidentical Peripheral Blood Stem Cell Transplantation (PBSCT)
20. Infusion of hemolyzed red blood cells within peripheral blood stem cell grafts in patients with and without sickle cell disease
21. Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia
22. Nonmyeloablative Hematopoietic Stem Cell Transplantation Improves a Marker of Diastolic Dysfunction in Patients with Sickle Cell Disease
23. 423 - Nonmyeloablative Hematopoietic Stem Cell Transplantation (HSCT) Improves Cardiac Function in Patients with Sickle Cell Disease (SCD)
24. Therapeutic Hydroxyurea Dosing Is Associated With Decreased Organ Damage and Longer Survival In Adults With Sickle Cell Anemia
25. Assessment Of The Endocrine Function Of Patients With Sickle Cell Disease After Allogeneic Hematopoietic Stem Cell Transplantation
26. Etiology of and Associations with Early Death in Adult Patients with Sickle Cell Disease At a Single Referral Institution.
27. Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Patients with Severe Sickle Cell Disease (SCD)
28. Pulmonary Hypertension in Adults and Children with Sickle Cell Disease in Nigeria: Prevalence, Clinical Characteristics and Role of Endemic Tropical Infections.
29. Severity of pulmonary hypertension during vaso‐occlusive pain crisis and exercise in patients with sickle cell disease
30. The Sickle Cell-Pulmonary Hypertension Screening Study: ECHO Findings at Two-Years of Follow Up.
31. Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients with Sickle Cell Disease.
32. Atorvastatin Therapy Restores Nitric Oxide-Dependent Vascular Responsiveness in Patients with Sickle Cell Disease.
33. Pulmonary Hypertension in Sickle Cell Disease: Cardiopulmonary Evaluation and Response to Chronic Phosphodiesterase 5 Inhibitor Therapy.
34. Acute on Chronic Pulmonary Hypertension in Patients with Sickle Cell Disease.
35. Divergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease
36. A machine learning‐based workflow for predicting transplant outcomes in patients with sickle cell disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.